Analytical Data
-
基因名
HAPLN2
- Application
-
别名
HAPLN2；BRAL1；Hyaluronan and proteoglycan link Protein 2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9GZV7
-
表达区间
27-340aa
-
氨基酸序列
DPASHPGPHYLLPPIHEVIHSHRGATATLPCVLGTTPPSYKVRWSKVEPGELRETLILITNGLHARGYGPLGGRARMRRGHRLDASLVIAGVRLEDEGRYRCELINGIEDESVALTLSLEGVVFPYQPSRGRYQFNYYEAKQACEEQDGRLATYSQLYQAWTEGLDWCNAGWLLEGSVRYPVLTARAPCGGRGRPGIRSYGPRDRMRDRYDAFCFTSALAGQVFFVPGRLTLSEAHAACRRRGAVVAKVGHLYAAWKFSGLDQCDGGWLADGSVRFPITTPRPRCGGLPDPGVRSFGFPRPQQAAYGTYCYAEN
-
分子量
40.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HAPLN2 (Hyaluronan-Interacting Protein 2) is a member of the HAPLN family, which plays a critical role in the extracellular matrix (ECM) organization and maintenance. The protein is known for its ability to interact with hyaluronic acid, a major component of the ECM, thereby influencing tissue structure and function. Studies have indicated that HAPLN2 is involved in various physiological processes, including cell adhesion, migration, and proliferation. Aberrant expression of HAPLN2 has been associated with several pathological conditions, including cancer progression and various inflammatory diseases. Given its significance in ECM dynamics and potential implications in disease, HAPLN2 has become an important target for research aimed at understanding ECM-related disorders and developing therapeutic strategies. Recombinant HAPLN2 protein has been produced for further studies, facilitating detailed investigations into its biological functions, interactions, and role in disease mechanisms. This research is not only pivotal for advancing our understanding of HAPLN2 in a physiological context but also for exploring its potential as a biomarker or therapeutic target in various diseases.
